{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:14:18Z","timestamp":1771640058365,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T00:00:00Z","timestamp":1280275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s12185-010-0642-5","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T05:35:37Z","timestamp":1280208937000},"page":"364-368","source":"Crossref","is-referenced-by-count":19,"title":["Epstein\u2013Barr virus-infected subcutaneous panniculitis-like T-cell lymphoma associated with methotrexate treatment"],"prefix":"10.1007","volume":"92","author":[{"given":"Yuiko","family":"Nemoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayuko","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Kamioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Nakaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Hiroi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Enzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Daibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,28]]},"reference":[{"key":"642_CR1","first-page":"343","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours. Lyon: IARC Press; 2008. p. 343\u20139."},{"key":"642_CR2","first-page":"350","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours","author":"P Gaulard","year":"2008","unstructured":"Gaulard P, Swerdlow SH, Harris NL, Jaffe ES, Sundstr\u00f6m C. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours. Lyon: IARC Press; 2008. p. 350\u20131."},{"key":"642_CR3","first-page":"322","volume":"34","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007;34:322\u201331.","journal-title":"J Rheumatol"},{"key":"642_CR4","first-page":"294","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours","author":"ES Jaffe","year":"2008","unstructured":"Jaffe ES, Gaulard P, Ralfkiaer E, Cerroni L, Meijer CJLM. Subcutaneous panniculitis-like T-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours. Lyon: IARC Press; 2008. p. 294\u20135."},{"key":"642_CR5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5858\/133.2.303","volume":"133","author":"Z Parveen","year":"2009","unstructured":"Parveen Z, Thompson K. Subcutaneous panniculitis-like T-cell lymphoma: redefinition of diagnostic criteria in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas. Arch Pathol Lab Med. 2009;133:303\u20138.","journal-title":"Arch Pathol Lab Med"},{"key":"642_CR6","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/PAS.0b013e31817a9081","volume":"32","author":"YY Kong","year":"2008","unstructured":"Kong YY, Dai B, Kong JC, Zhou XY, Lu HF, Shen L, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol. 2008;32:1495\u2013502.","journal-title":"Am J Surg Pathol"},{"key":"642_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/art.1780390223","volume":"39","author":"TR Bachman","year":"1996","unstructured":"Bachman TR, Sawitzke AD, Perkins SL, Ward JH, Cannon GW. Methotrexate-associated lymphoma in patients with rheumatoid arthritis: report of two cases. Arthritis Rheum. 1996;39:325\u20139.","journal-title":"Arthritis Rheum"},{"key":"642_CR8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1365-2141.2002.03619.x","volume":"118","author":"RD Baird","year":"2002","unstructured":"Baird RD, van Zyl-Smit RN, Dilke T, Scott SE, Rassam SMB. Spontaneous remission of low-grade B-cell non-Hodgkin\u2019s lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature. Br J Haematol. 2002;118:567\u20138.","journal-title":"Br J Haematol"},{"key":"642_CR9","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","volume":"99","author":"X Mariette","year":"2002","unstructured":"Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J, et al. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood. 2002;99:3909\u201315.","journal-title":"Blood"},{"key":"642_CR10","doi-asserted-by":"crossref","unstructured":"Hatachi S, Kunitomi A, Aozasa K, Yagita M. CD8+ T-cell lymphoproliferative disorder associated with Epstein\u2013Barr virus in a patient with rheumatoid arthritis during methotrexate therapy. Mod Rheumatol. 2010 (Published online).","DOI":"10.1007\/s10165-010-0300-z"},{"key":"642_CR11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/00000478-199807000-00010","volume":"22","author":"KE Salhany","year":"1998","unstructured":"Salhany KE, Macon WR, Choi JK, Elenitsas R, Lessin SR, Felgar RE, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha\/beta and gamma\/delta subtypes. Am J Surg Pathol. 1998;22:881\u201393.","journal-title":"Am J Surg Pathol"},{"key":"642_CR12","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","volume":"101","author":"JR Toro","year":"2003","unstructured":"Toro JR, Liewehr DJ, Pabby N, Sorbara L, Raffeld M, Steinberg SM, et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood. 2003;101:3407\u201312.","journal-title":"Blood"},{"key":"642_CR13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1365-2133.2003.05226.x","volume":"148","author":"SR Hoque","year":"2003","unstructured":"Hoque SR, Child FJ, Whittaker SJ, Ferreira S, Orchard G, Jenner K, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol. 2003;148:516\u201325.","journal-title":"Br J Dermatol"},{"key":"642_CR14","first-page":"103","volume":"258","author":"K Aozasa","year":"2001","unstructured":"Aozasa K, Kanno H, Miwa H, Tomita Y. EBV and malignant lymphoma with special emphasis on pyothorax-associated lymphoma. Curr Top Microbiol Immunol. 2001;258:103\u201320.","journal-title":"Curr Top Microbiol Immunol"},{"key":"642_CR15","doi-asserted-by":"crossref","unstructured":"Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342:575\u20137.","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"642_CR16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1440-1827.2009.02466.x","volume":"59","author":"Y Shimoyama","year":"2009","unstructured":"Shimoyama Y, Asano N, Kojima M, Morishima S, Yamamoto K, Oyama T, et al. Age-related EBV-associated B-cell lymphoproliferative disorders: diagnostic approach to an newly recognized clinicopathological entity. Pathol Int. 2009;59:835\u201343.","journal-title":"Pathol Int"},{"key":"642_CR17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/JVI.66.1.122-131.1992","volume":"66","author":"M Rowe","year":"1992","unstructured":"Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB. Three pathways of Epstein\u2013Barr virus gene activation from EBNA 1-positive latency in B lymphocytes. J Virol. 1992;66:122\u201331.","journal-title":"J Virol"},{"key":"642_CR18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0190-9622(98)70044-1","volume":"39","author":"AJ Craig","year":"1998","unstructured":"Craig AJ, Cualing H, Thomas G, Lamerson C, Smith R. Cytophagic histiocytic panniculitis\u2014a syndrome associated with benign and malignant panniculitis: case comparison and review of the literature. J Am Acad Dermatol. 1998;39:721\u201336.","journal-title":"J Am Acad Dermatol"},{"key":"642_CR19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archderm.1997.03890420133022","volume":"133","author":"K Iwatsuki","year":"1997","unstructured":"Iwatsuki K, Harada H, Ohtsuka M, Han G, Kaneko F. Latent Epstein\u2013Barr virus infection is frequently detected in subcutaneous lymphoma associated with hemophagocytosis but not in nonfatal cytophagic histiocytic panniculitis. Arch Dermatol. 1997;133:787\u20138.","journal-title":"Arch Dermatol"},{"key":"642_CR20","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/jnci\/djh313","volume":"96","author":"WH Feng","year":"2004","unstructured":"Feng WH, Cohen JI, Fischer S, Li L, Sneller M, Goldbach-Mansky R, et al. Reactivation of latent Epstein\u2013Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst. 2004;96:1691\u2013702.","journal-title":"J Natl Cancer Inst"},{"key":"642_CR21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.2004.030528","volume":"64","author":"P Geborek","year":"2005","unstructured":"Geborek P, Bladstr\u00f6m A, Turesson C, Gulfe A, Petersson IF, Saxne T, et al. Tumor necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis. 2005;64:699\u2013703.","journal-title":"Ann Rheum Dis"},{"key":"642_CR22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.22579","volume":"56","author":"F Wolfe","year":"2007","unstructured":"Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19, 562 patients during 89, 710 person-years of observation. Arthritis Rheum. 2007;56:1433\u20139.","journal-title":"Arthritis Rheum"},{"key":"642_CR23","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-2133.2009.09044.x","volume":"160","author":"C Michot","year":"2009","unstructured":"Michot C, Costes V, Gerard-Dran D, Guillot B, Combes B, Dereure O. Subcutaneous panniculitis-like T-cell lymphoma in a patient receiving etanercept for rheumatoid arthritis. Br J Dermatol. 2009;160:889\u201390.","journal-title":"Br J Dermatol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0642-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-010-0642-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0642-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T16:48:36Z","timestamp":1635785316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-010-0642-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,28]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["642"],"URL":"https:\/\/doi.org\/10.1007\/s12185-010-0642-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,28]]}}}